FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NVAX

Sort
E.g., 2013-05-18
E.g., 2013-05-18
Enter a comma separated list of user names.

HIV-PN is the most common neurological complication of HIV infection. Many patients with HIV are afflicted with symptoms ranging from mild tingling to severe and excruciating pain. HIV-PN is thought to be caused by multiple factors related to HIV infection including injury of sensory neurons by HIV virus proteins, the immune system's fight against HIV and some antiretroviral drugs.

Tags:

Global Hunter (GBLHF.PK)

Numerous factors come together to make copper one of the world's most sought-after and useful natural resources. Light, durable, corrosion-resistant, malleable, recyclable and an excellent conductor of electricity, this remarkable metal is being put to use in a growing number of industries.

Tags:

Discovery Laboratories Inc. (Nasdaq:DSCO) announced that the U.S. Food and Drug Administration (FDA) has deemed "complete" the company's Complete Response for SURFAXIN® (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants.

Tags:

Novavax, Inc. (Nasdaq:NVAX) announced the publication of an article that reported new safety, immunogenicity and cross-reactivity results from a Phase I/IIa clinical study of the company's H5N1 influenza virus-like particle (VLP) vaccine candidate that was conducted in 2008.

Tags:

Novavax, Inc. (Nasdaq:NVAX) announced the appointment of Timothy J. Hahn, Ph.D., as Senior Vice President of Manufacturing. Dr. Hahn will oversee production of the company's vaccines and vaccine candidates and be responsible for all manufacturing operations at its pilot and commercial launch facility in Rockville, MD. He will report to Novavax's President and CEO Stanley Erck.

Tags:

With the help of an expert in the field of Pharmacy, The Dean has posted an updating list of all potential swine flu stock plays. According to the author, the segmentation strategy was to focus on respiratory-related biotech stocks with existing momentum. It’s a pure gamble which of these stocks will catch ‘Swine Mania’ but the upside potential can be astronomical.

Pages

ADVERTISE WITH US